DaVita price target raised to $169 from $164 at Barclays

Barclays raised the firm’s price target on DaVita (DVA) to $169 from $164 and keeps an Equal Weight rating on the shares following the Q4 report. The company’s volumes still lag, but its 2025 guidance and phosphate binders screen conservative, the analyst tells investors in a research note.